BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) Peer Comparison
$15.89
As on 27-Aug-2026 16:04EDT
Market cap
$1,649 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
7.5
P/B Ratio
1
Div. Yield
0 %
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,649 | 3,291 | 2,089 | 1,892 | 1,599 |
Revenue ($ Mln) |
225 | 948 | 266 | 205 | 24 |
Net Profit ($ Mln) |
221.99 | -375.00 | 314.36 | 254.31 | 376.65 |
Net Margin (%) |
-- | -39.56 | -- | -- | 1,542.35 |
RoE (%) |
13.39 | -6.75 | 20.33 | 13.09 | 20.46 |
Price to Earnings |
7.50 | -- | 6.56 | 7.24 | 4.21 |
Price-To-Book |
1.04 | 0.65 | 1.22 | 0.98 | 0.93 |
Income Statement ($ Mln)
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
225.03 | 1,171.00 | 265.96 | 204.61 | 163.88 |
|
Cost of Revenue
|
1.43 | 356.00 | 20.58 | 8.19 | 13.88 |
|
Gross Profit
|
223.60 | 815.00 | 245.38 | 196.42 | 150.00 |
|
Operating Expenses
|
1.61 | 235.00 | -69.41 | -57.89 | -189.78 |
|
Operating Profit (EBIT)
|
221.99 | 580.00 | 314.79 | 254.31 | 339.84 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
221.99 | 23.00 | 314.36 | 254.31 | 339.84 |
|
Provision for Tax
|
-- | 12.00 | -- | -- | -- |
|
Profit after Tax (Net Income)
|
221.99 | 11.00 | 314.36 | 254.31 | 339.84 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | 11.00 | -- | -- | -- |
Liabilities ($ Mln)
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,595.29 | 5,849.00 | 1,717.10 | 1,982.80 | 1,756.14 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
93.32 | 7,880.00 | 18.50 | 2.44 | 16.88 |
|
Current Liabilities
|
277.11 | -- | 17.50 | 2.04 | 0.33 |
|
Total Liabilities
|
1,965.72 | 13,729.00 | 1,753.11 | 1,985.24 | 1,773.36 |
Assets ($ Mln)
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
1,958.96 | 13,548.00 | 1,721.20 | 1,972.27 | 1,772.94 |
|
Current Assets
|
6.75 | 181.00 | 31.91 | 12.97 | 0.42 |
|
Total Assets
|
1,965.72 | 13,729.00 | 1,753.11 | 1,985.24 | 1,773.36 |
|
Total Debt*
|
-- | 7,634.00 | 17.50 | -- | 1.80 |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
329.51 | 592.00 | -47.75 | -- | -- |
|
Cash Flow from Investing Activities
|
-- | 236.00 | 324.34 | -- | -- |
|
Cash from Financing Activities
|
-- | -679.00 | -256.13 | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
13.39 | 0.08 | 20.17 | 13.09 | 20.56 |
|
ROE (%)
|
13.39 | 0.18 | 20.33 | 13.09 | 20.58 |
|
ROA (%)
|
11.41 | 0.08 | 18.21 | 13.07 | 20.36 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
98.65 | 0.94 | 118.20 | 124.29 | 207.37 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.14 | 0.05 | -0.03 | -0.36 | -0.35 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
14.18 | -98.12 | 15.45 | -20.71 | 38.45 |
|
EPS Growth (%)
|
-- | -0.98 | -0.42 | -0.21 | 0.35 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 377.07 | 4.94 | 6.87 | 4.15 |
|
Price / Book Value
|
-- | 0.71 | 0.91 | 0.88 | 0.80 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-- | 17.44 | 4.90 | 6.87 | 4.15 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
-- | 1.31 | 0.01 | -- | 0.00 |
|
Short term debt to equity ratio
|
-- | 0.00 | 0.01 | -- | -- |
|
Current Ratio
|
0.02 | -- | 1.82 | 6.37 | 1.26 |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
-- | 1.05 | -- | -- | -- |
Operating Efficiency Ratios
| BlackRock Capital Allocation Trust of Beneficial Interest (BCAT) | FS KKR Capital (FSK) | BlackRock Science and Technology Trust II (BSTZ) | Tri Continental Closed Fund (TY) | General American Investors Closed Fund (GAM) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 35.10 | 0.59 | 6.25 | 1.57 |
|
Asset Turnover
|
0.12 | 0.08 | 0.15 | 0.11 | 0.10 |
|
Receivable days
|
18.07 | 122.27 | 1.18 | 21.00 | 15.90 |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
59,183.92 | 100.03 | 249.67 | 102.43 | 9.21 |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |